These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 25956656

  • 1. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG, Chen HL, Lu HY.
    BMC Cancer; 2015 May 10; 15():386. PubMed ID: 25956656
    [Abstract] [Full Text] [Related]

  • 2. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.
    Li L, Xu Y, Wang Y, Zhang Q, Wang Y, Xu C.
    Technol Cancer Res Treat; 2024 May 10; 23():15330338241265983. PubMed ID: 39043046
    [Abstract] [Full Text] [Related]

  • 3. [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].
    Duan X, Cui Y, Gong M, Tian F, Shi G, Wu B, Liu M, Guo J, Kong Y.
    Zhongguo Fei Ai Za Zhi; 2015 Jun 10; 18(6):358-64. PubMed ID: 26104892
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep 10; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer.
    Zhang ZH, Han YW, Liang H, Wang LM.
    Cancer Med; 2015 Nov 10; 4(11):1633-8. PubMed ID: 26333429
    [Abstract] [Full Text] [Related]

  • 6. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
    Cedrés S, Nuñez I, Longo M, Martinez P, Checa E, Torrejón D, Felip E.
    Clin Lung Cancer; 2011 May 10; 12(3):172-9. PubMed ID: 21663860
    [Abstract] [Full Text] [Related]

  • 7. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2011 May 10; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
    Zhao T, Mao G, Chen M.
    Comput Math Methods Med; 2021 May 10; 2021():1951364. PubMed ID: 34603482
    [Abstract] [Full Text] [Related]

  • 10. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec 10; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 11. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y, Shen W, Zhu M, Zhang L, Wei Y, Tang H, Zhao J.
    J Cell Biochem; 2019 Jan 10; 120(1):105-114. PubMed ID: 30216488
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
    Li L, Song LH, Ding SC, Zhang XJ, Qiang L, Han CY, Yuan XT, Xu DD.
    Zhonghua Zhong Liu Za Zhi; 2010 Nov 10; 32(11):850-4. PubMed ID: 21223692
    [Abstract] [Full Text] [Related]

  • 13. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 14. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X, Cui Y, Li H, Shi G, Wu B, Liu M, Chang D, Wang T, Kong Y.
    Indian J Cancer; 2015 Dec 08; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [Abstract] [Full Text] [Related]

  • 15. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients].
    Hang ZQ, Zheng MF, Huang JH.
    Zhonghua Zhong Liu Za Zhi; 2011 Nov 08; 33(11):847-9. PubMed ID: 22335951
    [Abstract] [Full Text] [Related]

  • 16. [Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer].
    Huang F, Wang XL, Yang L, Yin BX, Geng Y, Li TT.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr 08; 24(4):370-2. PubMed ID: 18394347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CEA, CYFRA21-1 and SCC in non-small cell lung cancer.
    Moro D, Villemain D, Vuillez JP, Delord CA, Brambilla C.
    Lung Cancer; 1995 Oct 08; 13(2):169-76. PubMed ID: 8581396
    [Abstract] [Full Text] [Related]

  • 19. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Zhang Z, Yuan F, Chen R, Li Y, Ma J, Yan X, Wang L, Zhang F, Tao H, Guo D, Huang Z, Zhang S, Li X, Zhi X, Ge X, Hu Y, Wang J.
    Front Immunol; 2020 Oct 08; 11():1173. PubMed ID: 32587591
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH, Song XR, Liu MQ, Zhang XQ, Zheng L, Li XJ, Liu PX.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 08; 26(6):345-8. PubMed ID: 15312344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.